Archives of Medical Research
Volume 41, Issue 1 , Pages 59-61, January 2010

Taurine: A Potential Novel Addition to the Anti-Systemic Sclerosis Weaponry

  • Mohammad Kazem Fallahzadeh

      Affiliations

    • Shiraz Nephrourology Research Center and Dermatology Department, Shiraz University of Medical Sciences, Shiraz, Iran
    • ,
  • Mohammad Reza Namazi

      Affiliations

    • Dermatology Department and Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
    • Corresponding Author InformationAddress reprint requests to: Mohammad Reza Namazi, MD, Dermatology Department, Faghihi Hospital, Shiraz, Iran; Phone and Fax: 00987112319049
    • ,
  • Ramesh C. Gupta

      Affiliations

    • SASRD Nagaland University, Medziphema, India

Received 6 July 2009; accepted 4 November 2009. published online 29 January 2010.

(ARCMED-09-00322)

Vascular damage and immunological events leading to generation of fibrogenic fibroblasts are the main components of systemic sclerosis (SSc) pathogenesis. Superoxide anions play a role in endothelial damage by oxidizing circulating low-density lipoproteins. IL-1 plays a key role in the pathophysiology of SSc by inducing upregulation of adhesion molecules, inflammatory damage of the endothelium and tissue fibrosis. Elevated levels of proTh2 cytokines such as IL-6 in the early stages of SSc lead to enhanced fibroblast collagen production.

Taurine, a semi-essential amino acid, is an antioxidant, inhibits the production of proinflammatory cytokines such as IL-1 and IL-6 and also inhibits production of TGF-β, a major fibrogenic cytokine.

Therefore, we conclude that taurine may be a novel addition to the treatment armamentarium of this disabling disorder.

Key Words: Taurine, Antioxidant, Fibrosis, TGF-β, IL-1, Autoimmunity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0188-4409(09)00212-4

doi:10.1016/j.arcmed.2009.11.005

Archives of Medical Research
Volume 41, Issue 1 , Pages 59-61, January 2010

Article Tools